Bill extends stem cell and cord blood transplant programs through 2031
Officially: Stem Cell Therapeutic and Research Reauthorization Act of 2025
Patients who need stem cell or cord blood transplants could keep using the national matching system for five more years. The bill extends existing programs through 2031 and sets the main transplant program at $33,009,000 a year from 2027 to 2031.
Where it stands
committee · Hearing Wed, Apr 15
In 5 days. Members are taking positions right now.
- Keeps the C.W. Bill Young Cell Transplantation Program in place under the Public Health Service Act.
- Sets federal funding for the program at $33,009,000 a year for fiscal years 2027 through 2031.
- Keeps the older $31,009,000 amount for earlier years already written into law. It adds new years instead of rewriting the whole section.
↓ Why your message matters here
Members are still deciding how to vote — and what they hear from constituents in these final days is what tips undecided ones.
The debate
What people are saying about this bill
- Keeps patients from losing access to matched stem cell and cord blood transplants if the current programs would otherwise expire.
- Raises funding a little, which could help the program handle higher costs and improve how it finds good donor matches.
- Keeps the cord blood supply available, which can matter for patients who have a hard time finding a match.
- Raises funding to $33,009,000 a year without giving more detailed proof about results or performance.
- Keeps federal spending in this area going when some people would rather leave more of that role to states or private groups.
- Continues federal support for stem cell-related work, which some people oppose even though this bill focuses on transplants and cord blood.
Where this bill is in the process
Legislative timeline
Introduced
Introduced in House
House Committee
Under House committee consideration
Latest: Referred to the House Committee on Energy and Commerce. (9/4/2025)
House Floor Vote
Voted on by House
Passed House
Approved by House
Senate Review
Sent to Senate for consideration
Passed Both Chambers
Approved by both House and Senate
Signed into Law
Signed by the President
For more detail